Ulrick Espelund

Ulrick Espelund

Auto-generated profile, based on publicly available information

Ulrick Espelund

Medical Research Laboratory, Department of Clinical Medicine, Faculty of Health, Aarhus University, DK-8000 Aarhus C, Denmark

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
MRMads Rasmussen
Mads Rasmussen
SSSilvia Schönenberger
Silvia Schönenberger
PHPia Löwhagen Hendèn
Pia Löwhagen Hendèn
JVJan B. Valentin
Jan B. Valentin
UEUlrick S. Espelund
Ulrick S. Espelund
FCFor The Saga Collaborators
For The Saga Collaborators
Endovascular therapy (EVT) improves neurologic outcome in patients with acute ischemic stroke (AIS) owing to large vessel occlusion.1-3 The optimal blood pressure targets during EVT for AIS have not been defined.4,5 Blood pressure is often lower in patients who receive general anesthesia (GA) for the EVT procedure than those who receive procedural sedation (PS), a factor that is considered a contributor to the worse outcomes associated with EVT under GA.6-11 It is conceivable that hypotensive episodes less than critical thresholds and their duration may influence collateral circulation, final infarct volume, and hence functional outcome.12-14 Since 2016, 3 randomized clinical trials, SIESTA (Sedation vs Intubation for Endovascular Stroke Treatment), ANSTROKE (Anesthesia During Stroke), and GOLIATH (General or Local Anesthesia in Intra-Arterial Therapy), demonstrated similar neurologic outcomes after EVT with GA and PS.15-17 Strict hemodynamic management according to specific blood pressure protocols may be an important part of the explanation for the equivalent outcomes in the randomized trials.15-17

1 February 2005 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
UEUlrick Espelund
Ulrick Espelund
THTroels Krarup Hansen
Troels Krarup Hansen
KHKurt Højlund
Kurt Højlund
HBHenning Beck-Nielsen
Henning Beck-Nielsen
JCJes Thorn Clausen
Jes Thorn Clausen
JFJan Frystyk
Jan Frystyk
Administration of ghrelin, the endogenous ligand for the GH secretagogue receptor, stimulates not only GH secretion but also appetite and food intake in humans. Endogenous ghrelin levels display a distinct circadian rhythm, which is reciprocal to that of insulin and presumed to be meal dependent and not associated with GH secretion. We tested the hypothesis that food deprivation could impact circadian serum ghrelin levels and unmask meal-independent regulatory mechanisms. Thirty-three young adults, subdivided according to gender and level of obesity, were studied with blood sampling every 3 h from 12-84 h of fasting. Serum ghrelin levels showed a marked diurnal rhythm with a nadir in the morning (0800 h), peak levels in the afternoon, and a gradual decline during the night. This pattern was preserved during the entire fasting period and was independent of gender and obesity. Mean 24-h ghrelin levels exhibited a small but significant decline during the fast (P < 0.001). As expected, GH secretion increased with fasting in lean subjects, and a gradual decline in insulin concentrations was observed in all subjects. Neither GH nor insulin showed any significant relationship to ghrelin. In contrast, serum cortisol exhibited a strong inverse temporal association with ghrelin (r = -0.79; P < 0.0001). In conclusion, our study yields no evidence that ghrelin stimulates GH release during fasting. As a novel finding, ghrelin appears to be related to cortisol. However, further studies are needed to elucidate the physiological mechanisms behind this relationship.

24 March 2005 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
JFJens Fuglsang
Jens Fuglsang
CSChristian Skjærbæk
Christian Skjærbæk
UEUlrick Espelund
Ulrick Espelund
JFJan Frystyk
Jan Frystyk
SFSanne Fisker
Sanne Fisker
POPer Ovesen
Per Ovesen

15 November 2021 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
SLSimon Meyer Lauritsen
Simon Meyer Lauritsen
BTBo Thiesson
Bo Thiesson
MJMarianne Johansson Jørgensen
Marianne Johansson Jørgensen
ARAnders Hammerich Riis
Anders Hammerich Riis
UEUlrick Skipper Espelund
Ulrick Skipper Espelund
JLJeppe Lange
Jeppe Lange
Problem framing is critical to developing risk prediction models because all subsequent development work and evaluation takes place within the context of how a problem has been framed and explicit documentation of framing choices makes it easier to compare evaluation metrics between published studies. In this work, we introduce the basic concepts of framing, including prediction windows, observation windows, window shifts and event-triggers for a prediction that strongly affects the risk of clinician fatigue caused by false positives. Building on this, we apply four different framing structures to the same generic dataset, using a sepsis risk prediction model as an example, and evaluate how framing affects model performance and learning. Our results show that an apparently good model with strong evaluation results in both discrimination and calibration is not necessarily clinically usable. Therefore, it is important to assess the results of objective evaluations within the context of more subjective evaluations of how a model is framed.

1 December 2003 in Growth Hormone & IGF Research
Verified
Journal Article
Closed access
CHCharlotte Höybye
Charlotte Höybye
BBBritta Barkeling
Britta Barkeling
UEUlrick Espelund
Ulrick Espelund
MPMaria Petersson
Maria Petersson
MTMarja Thorén
Marja Thorén

1 June 2018 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
MRM. Rasmussen
M. Rasmussen
UEU.S. Espelund
U.S. Espelund
NJN. Juul
N. Juul
AYA.J. Yoo
A.J. Yoo
LSL.H. Sørensen
L.H. Sørensen
CSC.Z. Simonsen
C.Z. Simonsen